Richard Peter Marshall insider trades

Open-market stock purchases and sales by Richard Peter Marshall, Director at Serina Therapeutics, Inc, from SEC Form 4 filings since Apr 1, 2024.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +27%.

Recent trades

DateStockTradeValue
Jun 17, 2026SER Serina Therapeutics, IncBought (not open market)—
May 19, 2026SER Serina Therapeutics, IncBought$20.1K
Nov 7, 2025SER Serina Therapeutics, IncBought (not open market)—

Companies traded

  • SER Serina Therapeutics, Inc: 1 buy, last Jun 17, 2026

Get free alerts when Richard Peter Marshall files a new trade →